GOTHENBURG, Sweden, June 30, 2026 /PRNewswire/ -- Oblique Therapeutics AB ("Oblique" or the "Company") today announces the outcome of the rights issue that closed on June 30. The rights issue was ...
Oblique Therapeutics AB Announces Outcome of Rights Issue of SEK 14.1 Million
Source: Finanznachrichten.de
Read Full Story →
